Addiction

atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference

NEW YORK and BERLIN, Sept. 14, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming…

1 year ago

Awakn Life Sciences Provides Corporate Update

Announces Closing of Third Tranche of Private PlacementToronto, Ontario--(Newsfile Corp. - September 14, 2023) - Awakn Life Sciences Corp. (NEO:…

1 year ago

It’s Back to School Across Ontario and Jack.org Has Launched a New Resource

Jack.org launches the Educator Hub, a new resource to support teachers in bringing vital mental health education to their students…

1 year ago

Awakn Life Sciences Submits Clinical Trial Application for Phase III Trial of AWKN-P001

AWKN-P001 is a N-methyl-D-aspartate Receptor-Modulating Drug Used in Combination with Psycho-Social Support for the Treatment of Severe Alcohol Use DisorderToronto,…

1 year ago

Lightning Step Names Healthcare IT Veteran Brent Michael as New CEO

HOUSTON--(BUSINESS WIRE)--Lightning Step, a leading provider of all-in-one CRM, EMR, and RCM solutions for behavioral health and addiction treatment centers,…

1 year ago

Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

CHARLOTTESVILLE, Va., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage…

1 year ago

Constellation Behavioral Health Welcomes New Executive Vice President of Business Development Rick Hubbard

Rick is an advocate, mentor, and trusted advisor with national reach, and we are thrilled to welcome him to our…

1 year ago